No results for ‘’
Senores Pharmaceuticals Ltd
NSE: SENORES BSE: 544319
₹1290
(11.14%)
Wed, 24 Jun 2026, 04:08 am
Market Cap (in Cr)5946.67
PE Ratio49.33
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KSenores Pharmaceuticals Cashflow
| Particulars | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Deprecation and amortization | -7.05M | -17.79M | -100.20M | -168.40M |
| Accumulated depreciation, total | -240.00K | -840.00K | -64.30M | -187.90M |
| Cash from operating activities | -107.64M | -28.77M | -337.40M | -591.20M |
| Funds from operations | 17.70M | 117.33M | 323.00M | 753.10M |
| Net income (cash flow) | 9.91M | 84.33M | 314.60M | 585.60M |
| Depreciation & amortization (cash flow) | 7.05M | 17.79M | 100.20M | 168.40M |
| Depreciation/depletion | 1.42M | 3.69M | 69.20M | 137.80M |
| Amortization | 5.63M | 14.10M | 31.00M | 30.60M |
| Deferred taxes (cash flow) | 0 | 0 | 800.00K | 0 |
| Non-cash items | -780.00K | -24.83M | -27.40M | -121.00M |
| Changes in working capital | -125.34M | -146.10M | -660.40M | -1.34B |
| Cash from investing activities | -220.93M | -495.06M | -560.50M | -4.37B |
| Capital expenditures | -106.81M | -472.77M | -518.30M | -1.58B |
| Capital expenditures - fixed assets | -106.81M | -472.77M | -518.30M | -1.58B |
| Capital expenditures - other assets | 0 | 0 | 0 | — |
| Cash from financing activities | 344.32M | 492.68M | 968.40M | 5.93B |
| Free cash flow | -214.45M | -501.54M | -855.70M | -2.17B |